Infektionen unter medikamentöser Immunsuppression bei transplantierten Intensivpatienten

Patienten sind nach einer soliden Organtransplantation anfälliger für Infektionen. Aufgrund oft untypischer klinischer Verläufe einer Infektion, erschwerter Diagnostik unter medikamentöser Immunsuppression und der Notwendigkeit zur Abklärung nichtinfektiöser Differenzialdiagnosen stellen diese eine besondere Herausforderung dar. Dieser Artikel soll für den auf der Intensivstation tätigen Arzt einen praxisbezogenen Überblick über Diagnose und Behandlung von Infektionen bei transplantierten Patienten geben.

• Literatur

• 1 Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614
• 2 Eutrotransplant. ET Yearly statistics overview – 2016. Im Internet: http://statistics.eurotransplant.org/reportloader.php?report=268803-6087&format=pdf Stand: 01.11.2017
• 3 Wiseman AC. Immunosuppressive Medications. Clin J Am Soc Nephrol 2016; 11: 332-343
• 4 Herzer K, Strassburg CP, Braun F. et al. Selection and use of immunosuppressive therapies after liver transplantation: current German practice. Clin Transplant 2016; 30: 487-501
• 5 Maier T, Schwarting A, Mauer D. et al. Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Clin Infect Dis 2010; 50: 1112-1119
• 6 Zhang Y, Ruiz P. Solid organ transplant-associated acute graft-versus-host disease. Arch Pathol Lab Med 2010; 134: 1220-1224
• 7 Parker A, Bowles K, Bradley JA. et al. Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients – BCSH and BTS Guidelines. Br J Haematol 2010; 149: 675-692
• 8 Speich R, van der Bij W. Epidemiology and management of infections after lung transplantation. Clin Infect Dis 2001; 33: S58-S65
• 9 Manuel O, López-Medrano F, Keiser L. et al. ESCMID Study Group of Infection in Compromised Hosts (ESGICH). Influenza and other respiratory virus infections in solid organ transplant recipients. Clin Microbiol Infect 2014; 20: 102-108
• 10 Negm AA, Schott A, Vonberg RP. et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010; 72: 284-291
• 11 Marco S, Cecilia F, Patrizia B. Neurologic complications after solid organ transplantation. Transpl Int 2009; 22: 269-278
• 12 Avery RK, Lonze BE, Kraus ES. et al. Severe chronic norovirus diarrheal disease in transplant recipients: Clinical features of an under-recognized syndrome. Transpl Infect Dis 2017; 19: e12674
• 13 Chapman JR, Marriott DJ, Chen SC. et al. Post-transplant Pneumocystis jirovecii pneumonia–a re-emerged public health problem?. Kidney Int 2013; 84: 240-243
• 14 Iriart X, Bouar M, Kamar N. et al. Pneumocystis pneumonia in solid-organ transplant recipients. J Fungi 2015; 1: 293-331
• 15 Paudel S, Zacharioudakis IM, Zervou FN. et al. Prevalence of clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies. PLoS One 2015; 10: e0124483
• 16 Nanayakkara D, Nanda N. Clostridium difficile infection in solid organ transplant recipients. Curr Opin Organ Transplant 2017; 22: 314-319
• 17 Kotton CN, Kumar D, Caliendo AM. et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplant J 2013; 96: 333-360
• 18 Gavaldà J, Meije Y, Fortún J. et al. Invasive fungal infections in solid organ transplant recipients. Clin Microbiol Infect 2014; 20: 27-48
• 19 Leblebicioglu H, Rodriguez-Morales AJ, Rossolini GM. et al. Management of infections in critically ill returning travellers in the intensive care unit I: considerations on infection control and transmission of resistance. Int J Infect Dis 2016; 48: 113-117